Hepatitis B vaccine: extending immunogenicity.
Horton
R C
RC
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000276:immunology*; D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral / Q000096:biosynthesis; D006509:Hepatitis B / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D006515:Hepatitis B virus / Q000276:immunology / Q000472:pathogenicity; D006801:Humans; D009894:Opportunistic Infections / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000276:immunology; D014612:Vaccines / Q000008:administration & dosage*; D014614:Vaccines, Synthetic / Q000008:administration & dosage* / Q000276:immunology; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D014612:Vaccines; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines